Resorcinol alkyl glucosides as potent tyrosinase inhibitors

Bioorg Med Chem Lett. 2019 Jan 15;29(2):313-316. doi: 10.1016/j.bmcl.2018.11.029. Epub 2018 Nov 14.

Abstract

Resorcinol alkyl glucosides 7-12 were developed as novel tyrosinase inhibitors based on the structure of rhododendrin. These were synthesized from 2,4-dibenzyloxybenzaldehyde using either the Wittig or the Horner-Wadsworth-Emmons reaction with Koenigs-Knorr glycosylation as key steps. The tyrosinase inhibitory activity of 7-12 increased with the length of the alkyl spacer between resorcinol and glucose. The 50% inhibitory concentration (IC50) of tetradecyl derivative 12 was 0.39 μM, making it the most potent of the compounds synthesized. The IC50 of 8 (3.62 μM) with a propyl spacer was ca 10 times that of 7 (35.9 μM) with an ethyl spacer. This significant activity difference suggests that an interaction between resorcinol alkyl glucoside and tyrosinase may increase remarkably if the length of the alkyl spacer exceeds C3.

Keywords: Alkyl spacer; Glycosylation; Resorcinol alkyl glucoside; Tyrosinase inhibitor.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alkylation
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Glucosides / chemical synthesis
  • Glucosides / chemistry
  • Glucosides / pharmacology*
  • Molecular Structure
  • Monophenol Monooxygenase / antagonists & inhibitors*
  • Monophenol Monooxygenase / metabolism
  • Resorcinols / chemical synthesis
  • Resorcinols / chemistry
  • Resorcinols / pharmacology*
  • Structure-Activity Relationship

Substances

  • Enzyme Inhibitors
  • Glucosides
  • Resorcinols
  • Monophenol Monooxygenase
  • resorcinol